chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 3 days post vaccination I began to notice that my lips were drying out. Dryness worsened and began cracking. 3 days later my lips began hurting. Tried to treat with OTC creams with no help. Began developing red rash around mouth and spreading to chin. October 9th or 10th I scheduled a telehealth appointment for a few days later. Doctor prescribed ELIDEL and doxycycline. After 3 days of treatment symptoms have stopped worsening.
I was tire from the moment I got t he shot.  Approximately twelve hours later I started filling pain in my neck and all over my back.  By 5 AM the pain was extreme and I felt confused.  I had diarrhea, naunsea, and extreme pain. My heart was going fast. I felt desperate.
Information has been received from a physician concerning a female (demographics not provided) who on 14-AUG-2007 was vaccinated with Gardasil (Lot# not reported).  That same day post vaccination the patient experienced dizziness.  Unspecified medical attention was sought.  Subsequently, on an unspecified date the patient recovered from dizziness.  Additional information has been requested.
Patient presented to pharmacy on 8/28/2020 with a swollen and red arm from elbow on up her arm. Shoulder was not red and lower arm was not red but patient stated that on 8/27/2020 whole arm was red and she could barely move arm. Treatment included Aleve, Benadryl, and hydrocortisone 1% cream
Rapid heart rate 120 at rest the morning after the shot, blood pressure elevated than my normal 145/90, hives/rash on both forearms, legs, trunk, and back, left armpit swollen and painful.
At around 1310 patient patient verbalized that she feels her throat is swollen. noted redness around both eyes. b/p 159/81, pulse rate 105/min. Benadryl 50mg ivp given. O2 administered at 2lpm/NC. At 1330 after treatment, patient still not feeling well, c/o feeling that her leg is swollen and heavy. epinephrine 0.3mg given IM. b/p 177/77, pulse rate 106/min. Dr, on call nephrologist notified. Called 911. Report given to paramedics. patient's daughter notified. Patient sent to ER accompanied by paramedics and patient's husband.
bright red rash on feet, around ankles, and up the lower leg for a week  Pharmacist suggested I take a Zertech type anihistimine during the day and benedrill at night .
Pt c/o lightheaded, "sight went black" 2 mins after receiving vaccine. She reports that she gets these feeling when she gets vaccines, last one was Hep B vaccine dose #1 3 months ago. She denied any other past med hx. Pt assessed and monitored by NP, EMT.
On 6/3/99, the pt experienced erythematous and papular rash with low-grade temperature. The pt was presented to a physician with symptoms.
Effects; I had the injection (2nd dose - first was a Pfizer; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Effects) and INTERCHANGE OF VACCINE PRODUCTS (I had the injection (2nd dose - first was a Pfizer) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jun-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (I had the injection (2nd dose - first was a Pfizer). On an unknown date, the patient experienced VACCINATION COMPLICATION (Effects). At the time of the report, VACCINATION COMPLICATION (Effects) and INTERCHANGE OF VACCINE PRODUCTS (I had the injection (2nd dose - first was a Pfizer) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  On 01 Apr 2021, the patient received the first dose of the Pfizer vaccine.  No treatment information was provided.
patient's face is swollen; stomach is nauseated; joint pain in the collarbone and neck; Neck hurt; mother's collarbone neck area began hurting; left ear/side of face felt it numb and hurting; left ear/side of face felt it numb and hurting; left ear pain; she couldn't sleep last night; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (Neck hurt), BONE PAIN (mother's collarbone neck area began hurting), HYPOAESTHESIA (left ear/side of face felt it numb and hurting), FACIAL PAIN (left ear/side of face felt it numb and hurting) and EAR PAIN (left ear pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN, VENLAFAXINE, ACETYLSALICYLIC ACID (ECOTRIN), PANTOPRAZOLE, HYDROCHLOROTHIAZIDE, LISINOPRIL and FAMOTIDINE for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced NECK PAIN (Neck hurt), BONE PAIN (mother's collarbone neck area began hurting), HYPOAESTHESIA (left ear/side of face felt it numb and hurting), FACIAL PAIN (left ear/side of face felt it numb and hurting), EAR PAIN (left ear pain), INSOMNIA (she couldn't sleep last night) and ARTHRALGIA (joint pain in the collarbone and neck). On 15-Apr-2021, the patient experienced SWELLING FACE (patient's face is swollen) and NAUSEA (stomach is nauseated). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and GABAPENTIN at an unspecified dose and frequency. At the time of the report, NECK PAIN (Neck hurt), BONE PAIN (mother's collarbone neck area began hurting), HYPOAESTHESIA (left ear/side of face felt it numb and hurting), FACIAL PAIN (left ear/side of face felt it numb and hurting), EAR PAIN (left ear pain), INSOMNIA (she couldn't sleep last night), SWELLING FACE (patient's face is swollen), ARTHRALGIA (joint pain in the collarbone and neck) and NAUSEA (stomach is nauseated) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication includes Cough medications
Rash and pain at injection site, rash extending approx 4" x 4" and lasting approx 5 days
Patient was given Monderna Vaccine first dose on 7/27/2021 at Pharmacy, today on 8/24/21 he came in to Pharmacy store to get his second dose. However, he was administered Pfizer for his second dose.
8SEP93 presents w/red rash over most of body 5-20min in size, genrrally round w/raised edges some confluent; had some low grade fever & nasal drainage; 10SEP93 erythema multiform;
Administered shot, patient moved to post-vaccination seating area. Within 5 minutes he complained about lightheadedness and appeared pale. Patient was given water and a fan. Requested patient stay an extra 15 minutes until he was feeling better. Patient left after 40 minutes of sitting.
Information has been received from a physician concerning a 24 year old female patient who on 13-JUN-2007, was vaccinated into the left deltoid with a first dose of Gardasil (Lot # 657621/0387U). On 04-JUL-2007 about three weeks after injection, the patient experienced a recurrence of erythema multiforme. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
pt recv vax JUN97 & 3 days p/exposure pt devel a cough that was dry & productive @ times;
FEVER STARTEDE 12/16/2003 THEN DEVELOPED CHEST AND NASAL CONGESTION.
PT was suppose to get Covid Pfizer Bivalent but instead received Covid19 Pfizer Biontech. Will also report and will contact pt to advise he can get the Bivalent in 2 months from 9/26/22.
43 y/o male, past medical history of Hypertension (untreated) presents with numbness to the left ear, left neck and left upper arm shortly after vaccination. Vaccination site was the left deltoid. NP and Paramedics at side. Negative Stroke Scale. Vitals taken and patient noted to be hypertensive with BPs ranging between 145/94-166/114, all other vitals normal. Advised patient on the need to transport to the ER via Fire Rescue due to symptoms and bps. Fire rescue arrive on scene where patient refused transport. Patient signed our AMA form in addition to Fire Rescues AMA form. Patient left on his own account.----------------------End.
face swells up at night; itching; severe rashes which looks like measles on her hands, face, and neck.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (severe rashes which looks like measles on her hands, face, and neck.), SWELLING FACE (face swells up at night) and PRURITUS (itching) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included blood pressure medication for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced RASH (severe rashes which looks like measles on her hands, face, and neck.). On an unknown date, the patient experienced SWELLING FACE (face swells up at night) and PRURITUS (itching). At the time of the report, RASH (severe rashes which looks like measles on her hands, face, and neck.), SWELLING FACE (face swells up at night) and PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-094916 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-094916:
Patient has hx of radiation cystitis with mild hematuria; following vaccination her hematuria dramatically worsened requiring hospitalization and transfusion of blood.
Fatigue and ache; Fatigue and ache; Swollen lymph and painful node in armpit and breast on the same side as vaccination. Approximately a mandarin-orange-sized swelling of the lymph node.; Swollen and painful lymph node in armpit and breast on the same side as vaccination; Off label use; A third (booster) dose of BNT162b2 is administered subsequent to the Initial 2 dose regimen of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Oct2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included dexamfetamine sulfate (ZENZEDI), lamotrigine (LAMICTAL) and ibuprofen (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01Apr2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 03Oct2021, day after vaccination, the patient experienced fatigue and ache, swollen and painful lymph node in armpit and breast on the same side as vaccination, approximately a mandarin-orange-sized swelling of the lymph node. On 03Oct2021, the patient underwent pain scale test and the result was pain on scale of 1-10 was a 4. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, fatigue and ache, swollen and painful lymph node in armpit and breast on the same side as vaccination, approximately a mandarin-orange-sized swelling of the lymph node was resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
a small rash on her back and chest; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) on an unspecified date (lot/batch number and expiration date not provided), the second dose on 05Feb2021 (lot number: lot number: EL9269), both via an unspecified route of administration at single dose as COVID-19 Vaccine. Medical history included Hypertension, Prediabetes. The patient's concomitant medications were not reported. Caller stated she had gotten the second covid vaccine shot yesterday and had gotten a small rash on her back and chest. Caller wanted to know if it is from the covid vaccine. Consumer further stated she was just wondering if and she had just gotten her second shot yesterday, but after her first shot she had gotten a little bit of a rash on her back and on her chest and she wonder if that were a common occurrence or side effect of this shot. Consumer stated no treatment. No Investigation Assessment. The outcome of the event was unknown.  Information about the lot/batch number has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 19-DEC-2012, a health care provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 13-OCT-2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
had a vaxxxcccine and got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine and Flu vaccine. On an unknown date, unknown after receiving Shingles vaccine and Flu vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Flu vaccine.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patients got the Shingle vaccine and Flu shots and got shingles. The reporter knew of about ten people who had it and all ten received multiple vaccines. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
General malaise; Bruise with a 6 inch radius at the injection site/It was bruised for 4-5 days; Swelling at the injection site; Fever; Redness at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (General malaise), VACCINATION SITE BRUISING (Bruise with a 6 inch radius at the injection site/It was bruised for 4-5 days), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B, 029L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, the patient experienced MALAISE (General malaise), VACCINATION SITE BRUISING (Bruise with a 6 inch radius at the injection site/It was bruised for 4-5 days), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness at the injection site). In December 2021, VACCINATION SITE BRUISING (Bruise with a 6 inch radius at the injection site/It was bruised for 4-5 days) had resolved. At the time of the report, MALAISE (General malaise), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
This spontaneous report was received from a male consumer of unknown age, referring to himself. The patient had no known drug reactions/allergies and with no relevant medical history. On 10-SEP-2014, the patient was vaccinated with ZOSTAVAX one time vaccine (route, lot # and expiration date were not provided). The patient did not have any concomitant medication. The patient stated that he got shingles on 03-JAN-2015, he had little scratch on forehead and on 04-JAN-2015, reported as the next day, his left eye was swollen, he could not open his left eye. On 06-JAN-2015, reported as 3 days later, the patient saw a dermatologist, who prescribed him an Valacyclovir and his eye doctor prescribed ZIRGAN. It was also reported that a blood test was performed 2 months ago (results were not provided) and no PQC was involved. At the time of the report, the outcome of shingles and eye swelling was unknown. The reporter did not provide a causality assessment for this case. Additional information has been requested.
Patient called on 1/25/21 and spoke with pharmacist. He reported that he is still having pain at injection site including muscle pain that is radiating into his neck and causing muscle spasms. He reported it to his doctor who told him to contact us at the pharmacy who administered the immunization.  Patient reported using ice, heating pad, Tylenol, Ibuprofen, and has seen a chiropractor and still has no relief.
hasn't eaten much; nauseous; trouble sleeping; Sick; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (trouble sleeping), ILLNESS (Sick), DECREASED APPETITE (hasn't eaten much) and NAUSEA (nauseous) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (The patient blood pressure would normally be high). Concomitant products included VALSARTAN for an unknown indication.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced INSOMNIA (trouble sleeping), ILLNESS (Sick) and NAUSEA (nauseous). On an unknown date, the patient experienced DECREASED APPETITE (hasn't eaten much). At the time of the report, INSOMNIA (trouble sleeping), ILLNESS (Sick), DECREASED APPETITE (hasn't eaten much) and NAUSEA (nauseous) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, Blood pressure measurement: 120/80 mmHg (normal) 120/80.         Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications included Valsartan, but the patient did not take medicine as blood pressure was in normal range, which would normally be high.  The patient did not experience any side effects with first dose.
- Twitching of eyes for 24 hrs. (had Cataract surgery on both eyes with enhanced vision implants April & May 2021)  - Sharp shooting throbbing pain on right neck artery (lasted for 2 days) / Could feel a strong pulse / heart beat  - Dark Lines appeared from corner of both eyes up to eye brows
This is a spontaneous report from a non clinical study program. A 51-year-old male patient received a shot of PREVNAR 13, on last week of Mar2014 at single dose. The patient mentioned that doctor gave PREVNAR 13 to him because he was HIV positive (since 17 years). The patient was very healthy before vaccination. On an unknown date in 2014 he had a very bad reaction, he had bruises and blister on his eyelid, rash and blister all over his body, severe swelling in his feet, fever, he blacked out a few times and he had surgery on his eyes. The doctor said that it was the result of PREVNAR 13. Patient also had darkening of his toenails and it was reported that "it looked like he had full blown AIDS". He has not undergone any blood test recently. The outcome of the events was unknown.
Approximately, 7 to 10 minutes after the pharmacist administered the vaccine to the patient, the patient experienced a vasovagal syncope event.  The patient briefly lost consciousness for approximately 60 to 90 seconds.  The pharmacist was able to catch the patient as she lost consciousness and began to fall from the chair where she was seated.  The patient was then moved to a recovery position on the floor, where she then regained consciousness shortly thereafter.  The pharmacist attended to the patient while she was unconscious and as she began to regain consciousness.  The patient's husband was contacted and he then presented to the pharmacy.  After being monitored in the pharmacy area for approximately 15 to 20 minutes after fully recovering, the patient's husband then took the patient home.
Case previously recorded as MA2009-5699. We received the following information from a consumer via LAREB, and Novartis Pharma on the 20 NOV 2009. This 3-year-old male patient, was vaccinated with 1 DF S-OIV FLUVIRIN (batch number 1012781) on an unknown date. Ref no. NA09-008676.